Alaunos Therapeutics Inc (TCRT) concluded trading on Wednesday at a closing price of $2.80, with 13.63 million shares of worth about $38.17 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -13.04% during that period and on April 03, 2025 the price saw a gain of about 29.63%. Currently the company’s common shares owned by public are about 1.60M shares, out of which, 1.38M shares are available for trading.
Stock saw a price change of 83.01% in past 5 days and over the past one month there was a price change of 87.92%. Year-to-date (YTD), TCRT shares are showing a performance of 46.98% which decreased to -84.00% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.31 but also hit the highest price of $18.50 during that period. The average intraday trading volume for Alaunos Therapeutics Inc shares is 102.00K. The stock is currently trading 75.04% above its 20-day simple moving average (SMA20), while that difference is up 72.26% for SMA50 and it goes to 1.83% higher than SMA200.
Alaunos Therapeutics Inc (NASDAQ: TCRT) currently have 1.60M outstanding shares and institutions hold larger chunk of about 4.51% of that.
The stock has a current market capitalization of $4.49M and its 3Y-monthly beta is at -1.01. It has posted earnings per share of -$2.92 in the same period. It has Quick Ratio of 3.98 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TCRT, volatility over the week remained 35.12% while standing at 11.61% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on October 04, 2022 offering an Overweight rating for the stock and assigned a target price of $3 to it.
